Early alterations in ovarian surface epithelial cells and induction of ovarian epithelial tumors triggered by loss of FSH receptor

Neoplasia

Volumn 9, Issue 6, 2007, Pages 521-531

  Chen, Xinlei ^a   Aravindakshan, Jayaprakash ^a   Yang, Yinzhi ^a   Sairam, M Ram ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Chronology; Cytokeratin; FORKO mouse; Ovarian tumor; Surface epithelium

Indexed keywords

CYCLINE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOKERATIN; FOLLITROPIN RECEPTOR; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; TRANSCRIPTION FACTOR GATA 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER MODEL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; CHRONOLOGY; CONTROLLED STUDY; CYSTADENOMA; EPITHELIUM CELL; FEMALE; HISTOLOGY; INFLAMMATION; MOUSE; MUTANT; NONHUMAN; OVARY; OVARY CARCINOMA; OVULATION; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING;

EID: 34250881508     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.07238     Document Type: Article

References (47)

1. Zanagnolo V, Sartori E, Trussardi E, Pasinetti B, and Maggino T (2005). Preservation of ovarian function, reproductive ability and emotional attitudes in patients with malignant ovarian tumors. Eur J Obstet Gynecol Reprod Biol 123, 235-243.
2. Holschneider CH and Berek JS (2000). Ovarian cancer: epidemiology, biology, and prognostic factors. Semin Surg Oncol 19, 3-10.
3. Risch HA (1998). Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 90, 1774-1786.
4. Auersperg N, Wong AS, Choi KC, Kang SK, and Leung PC (2001). Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 22, 255-288.
5. Murdoch WJ and McDonnel AC (2002). Roles of the ovarian surface epithelium in ovulation and carcinogenesis. Reproduction 123, 743-750.
6. Auersperg N, Edelson MI, Mok SC, Johnson SW, and Hamilton TC (1998). The biology of ovarian cancer. Semin Oncol 25, 281-304.
7. Fleming JS, Beaugie CR, Haviv I, Chenevix-Trench G, and Tan OL (2006). Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses. Mol Cell Endocrinol 247, 4-21.
8. Tan OL, Hurst PR, and Fleming JS (2005). Location of inclusion cysts in mouse ovaries in relation to age, pregnancy, and total ovulation number: implications for ovarian cancer? J Pathol 205, 483-490.
9. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, and Thun MJ (2005). Cancer statistics, 2005. CA Cancer J Clin 55, 10-30.
10. Davies BR, Finnigan DS, Smith SK, and Ponder BA (1999). Administration of gonadotropins stimulates proliferation of normal mouse ovarian surface epithelium. Gynecol Endocrinol 13, 75-81.
11. Parrott JA, Doraiswamy V, Kim G, Mosher R, and Skinner MK (2001). Expression and actions of both the follicle stimulating hormone receptor and the luteinizing hormone receptor in normal ovarian surface epithelium and ovarian cancer. Mol Cell Endocrinol 172, 213-222.
12. Stewart SL, Querec TD, Gruver BN, O'Hare B, Babb JS, and Patriotis C (2004). Gonadotropin and steroid hormones stimulate proliferation of the rat ovarian surface epithelium. J Cell Physiol 198, 119-124.
13. Syed V, Ulinski G, Mok SC, Yiu GK, and Ho SM (2001). Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells. Cancer Res 61, 6768-6776.
14. Choi JH, Choi KC, Auersperg N, and Leung PC (2006). Gonadotropins activate proteolysis and increase invasion through protein kinase A and phosphatidylinositol 3-kinase pathways in human epithelial ovarian cancer cells. Cancer Res 66, 3912-3920.
15. Siemens CH and Auersperg N (1988). Serial propagation of human ovarian surface epithelium in tissue culture. J Cell Physiol 134, 347-356.
16. Dabrow MB, Francesco MR, McBrearty FX, and Caradonna S (1998). The effects of platelet-derived growth factor and receptor on normal and neoplastic human ovarian surface epithelium. Gynecol Oncol 71, 29-37.
17. Danilovich N, Roy I, and Sairam MR (2001). Ovarian pathology and high incidence of sex cord tumors in follitropin receptor knockout (FORKO) mice. Endocrinology 142, 3673-3684.
18. Balla A, Danilovich N, Yang Y, and Sairam MR (2003). Dynamics of ovarian development in the FORKO immature mouse: structural and functional implications for ovarian reserve. Biol Reprod 69, 1281-1293.
19. Aravindakshan J, Chen X, and Sairam MR (2006). Differential expression of claudin family proteins in mouse ovarian serous papillary epithelial adenoma in aging FSH receptor deficient mutants. Neoplasia 8, 984-994.
20. Chen X, Aravindakshan J, Yang Y, Tiwari-Pandey R, and Sairam MR (2006). Aberrant expression of PDGF ligands and receptors in the tumor prone ovary of follitropin receptor knockout (FORKO) mouse. Carcinogenesis 27, 903-915.
21. Danilovich N, Babu PS, Xing W, Gerdes M, Krishnamurthy H, and Sairam MR (2000). Estrogen deficiency, obesity, and skeletal abnormalities in follicle-stimulating hormone receptor knockout (FORKO) female mice. Endocrinology 141, 4295-4308.
22. Milikowski CBI (1997). Color Atlas of Basic Histopathology Appleton and Lange, Stamford.
23. Liebelt AG, Sass B, and Lombard LS (1987). Mouse ovarian tumors - a review including classification and induction of neoplastic lesions and description of several previously unreported types. J Exp Pathol 3, 115-145.
24. Maronpot RR (1999). Pathology of Mouse. Cache River. Clearwater, FL.
25. Roby KF, Taylor CC, Sweetwood JP, Cheng Y, Pace JL, Tawfik O, Persons DL, Smith PG, and Terranova PF (2000). Development of a syngeneic mouse model for events related to ovarian cancer. Carcinogenesis 21, 585-591.
26. Abel MH, Huhtaniemi I, Pakarinen P, Kumar TR, and Charlton HM (2003). Age-related uterine and ovarian hypertrophy in FSH receptor knockout and FSHbeta subunit knockout mice. Reproduction 125, 165-173.
27. Crist KA, Zhang Z, You M, Gunning WT, Conran PB, Steele VE, and Lubet RA (2005). Characterization of rat ovarian adenocarcinomas developed in response to direct instillation of 7,12-dimethylbenz[a]anthracene (DMBA) coated suture. Carcinogenesis 26, 951-957.
28. Connolly DC, Bao R, Nikitin AY, Stephens KC, Poole TW, Hua X, Harris SS, Vanderhyden BC, and Hamilton TC (2003). Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer. Cancer Res 63, 1389-1397.
29. Lassus H, Laitinen MP, Anttonen M, Heikinheimo M, Aaltonen LA, Ritvos O, and Butzow R (2001). Comparison of serous and mucinous ovarian carcinomas: distinct pattern of allelic loss at distal 8p and expression of transcription factor GATA-4. Lab Invest 81, 517-526.
30. Daikoku T, Tranguch S, Trofimova IN, Dinulescu DM, Jacks T, Nikitin AY, Connolly DC, and Dey SK (2006). Cyclooxygenase-1 is overexpressed in multiple genetically engineered mouse models of epithelial ovarian cancer. Cancer Res 66, 2527-2531.
31. Dierich A, Sairam MR, Monaco L, Fimia GM, Gansmuller A, LeMeur M, and Sassone-Corsi P (1998). Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc Natl Acad Sci USA 95, 13612-13617.
32. Fathalla MF (1971). Incessant ovulation - a factor in ovarian neoplasia? Lancet 2, 163.
33. Zheng W, Magid MS, Kramer EE, and Chen YT (1996). Follicle-stimulating hormone receptor is expressed in human ovarian surface epithelium and fallopian tube. Am J Pathol 148, 47-53.
34. Osterholzer HO, Streibel EJ, and Nicosia SV (1985). Growth effects of protein hormones on cultured rabbit ovarian surface epithelial cells. Biol Reprod 33, 247-258.
35. Lau KM, Mok SC, and Ho SM (1999). Expression of human estrogen receptor-alpha and -beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells. Proc Natl Acad Sci USA 96, 5722-5727.
36. Adams AT and Auersperg N (1983). Autoradiographic investigation of estrogen binding in cultured rat ovarian surface epithelial cells. J Histochem Cytochem 31, 1321-1325.
37. Dubeau L (1999). The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes? Gynecol Oncol 72, 437-442.
38. Vanderhyden BC (2005). Loss of ovarian function and the risk of ovarian cancer. Cell Tissue Res 322, 117-124.
39. Ilekis JV, Connor JP, Prins GS, Ferrer K, Niederberger C, and Scoccia B (1997). Expression of epidermal growth factor and androgen receptors in ovarian cancer. Gynecol Oncol 66, 250-254.
40. Helzlsouer KJ, Alberg AJ, Gordon GB, Longcope C, Bush TL, Hoffman SC, and Comstock GW (1995). Serum gonadotropins and steroid hormones and the development of ovarian cancer. JAMA 274, 1926-1930.
41. Silva EG, Tornos C, Fritsche HA Jr, el Naggar A, Gray K, Ordonez NG, Luna M, and Gershenson D (1997). The induction of benign epithelial neoplasms of the ovaries of guinea pigs by testosterone stimulation: a potential animal model. Mod Pathol 10, 879-883.
42. Molkentin JD (2000). The zinc finger-containing transcription factors GATA-4, -5, and -6. Ubiquitously expressed regulators of tissue-specific gene expression. J Biol Chem 275, 38949-38952.
43. Laitinen MP, Anttonen M, Ketola I, Wilson DB, Ritvos O, Butzow R, and Heikinheimo M (2000). Transcription factors GATA-4 and GATA-6 and a GATA family cofactor, FOG-2, are expressed in human ovary and sex cord-derived ovarian tumors. J Clin Endocrinol Metab 85, 3476-3483.
44. Capo-chichi CD, Roland IH, Vanderveer L, Bao R, Yamagata T, Hirai H, Cohen C, Hamilton TC, Godwin AK, and Xu XX (2003). Anomalous expression of epithelial differentiation - determining GATA factors in ovarian tumorigenesis. Cancer Res 63, 4967-4977.
45. Dannenberg AJ, Altorki NK, Boyle JO, Dang C, Howe LR, Weksler BB, and Subbaramaiah K (2001). Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer. Lancet Oncol 2, 544-551.
46. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, and DuBois RN (1998). Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93, 705-716.
47. Tsujii M, Kawano S, and DuBois RN (1997). Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 94, 3336-3340.